Analysis of expression profile of gene encoding proteins of signal cascades activated by insulin-like growth factors in colorectal cancer

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 3, 2011, Pages 781-787

  Nowakowska Zajdel, E ^a   Mazurek, U ^a   Ziołko E ^a   Niedworok, E ^a   Fatyga, E ^a   Kokot, T ^a   Muc Wierzgoń, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Colorectal cancer; IGF system; Signal transduction

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 10; MESSENGER RNA; PROTEIN; PROTEIN IRS1; PROTEIN PIK3R1; PROTEIN PIK3R3; SMAD2 PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CANCER PATIENT; CONTROLLED STUDY; GENE; GENETIC TRANSCRIPTION; HUMAN TISSUE; IRS1 GENE; PIK3R1 GENE; PIK3R3 GENE;

EID: 80055102584     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400324     Document Type: Article

References (21)

1. Renehan AG, Zwahlen M, Minder Ch, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor, IGF-binding protein-3 and cancer risk: systematic review and meta-regression analysis. Lancet 2001; 363:1346-53.
2. Cohen P, Clemmons DR, Rosenfeld R. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 2000; 10:297-305. (Pubitemid 32125100)
3. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dachaud H. Serum C-Peptide, Insulin-like Growth Factor, IGF-Binding Proteins and Colorectal Cancer Risk in Women. J Natl Cancer Inst 2000; 92:-1592-600.
4. Chan JM, Stamfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannuci E. Insulin-like growth factor-1 and IGF binding protein -3 as a predictor of advanced -stage prostate cancer. Prostate 2003; 54:125-32.
5. Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 2002; 63:317-32. (Pubitemid 36151524)
6. O'Dell SD, Day IN. Molecules in focus: insulin-like growth factor-II. Int J Biochem Cell Biol 1998; 30:767-77.
7. Dupont J, Piene A, Froment P, Moreau C. The insulin-like growth factor axis in cell cycle progression. Horm Metab Res 2003; 35:740-50. (Pubitemid 38058178)
8. Hamelers IH, Van Schaik RF, Sipkema J, Sussenbach JS, Steenbergh PH. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells. J Biol Chem 2002; 277:47645-52. (Pubitemid 36159286)
9. Stromberg T, Ekman S, Girnita L, Dimberg LY, Larsson O, Axelson M. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M phase accumulation and apoptosis in multiple myeloma cells. Blood 2006; 107:669-78. (Pubitemid 43076393)
10. Stachowicz M, Mazurek U, Nowakowska-Zajdel E, Niedworok E, Fatyga E, Muc-Wierzgoń M. Leptin and its receptors in obese patients with colorectal cancer. J Biol Regul Homeost Agents 2010; 24:287-95.
11. Lee OH, Bae SK, Mae MH. Identification of angiogenic properties of insulin-like growth factor II in vitro angiogenesis models. Br J Cancer 2000; 82:385-91. (Pubitemid 30045386)
12. Reinmuth N, Fan F, Liu W, Parkih AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallic GE. Impact of Insulin-like growth factor receptor-1 function on angiogenesis, growth, metastasis of colon cancer. Lab Invest 2002; 82:1377-89. (Pubitemid 35191541)
13. Zeng H, Datta K, Neid M, Li J, Parangi S, Mukhopadhyay D. Requirement of different signaling pathways mediated by insulin-like growth factor-1 receptor for proliferation, invasion and VPF/ VEGF expression in pancreatic carcinoma cell line. Biochem Biophys Res Commun 2003; 302:46-55. (Pubitemid 36268917)
14. Nakamura M, Miyamoto S, Maeda H. Matrix metalloproteinase-7 degrades All insulin-like growth factor-binding proteins and facilitates insulin like growth factor bioavailability. Biochem Biophys Res Commun 2005; 333:1011-16. (Pubitemid 40854257)
15. Zhang D, Samani AA, Brodt P. The role of the IGF-1 receptor In the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res 2003; 35:802-808. (Pubitemid 38058186)
16. Li SR, Ng CFJ, Banerjea A, Ahmed S, Hands R, Powar M. Differential expression patterns of insulin-like growth factor 2 gene in human colorectal cancer. Tumor Biol 2004; 25:62-68. (Pubitemid 38822773)
17. Chang Q, Li Y, White MF, Fletcher JA, Xiao S. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: Therapeutic implications. Cancer Res 2002; 14:733-40.
18. Ge H, Walhout AJ, Vidal M. Integrating 'omic' information: A bridge between genomics and systems biology. Trends Genet 2003; 19:551-60. (Pubitemid 37204914)
19. Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol 2005; 23:1803-10. (Pubitemid 46211358)
20. Barnes CJ, Ohoshiro K, Rayala SK, El-Naggar AK, Kumar R. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Clin Cancer Res 2007; 13:4291-99. (Pubitemid 47105993)
21. Ryan PD, Goss PE. The Emerging role of the insulin-like growth factor pathways as a therapeutic target in cancer. Oncologist 2008; 13:16-24. (Pubitemid 351206693)